PhRMA
OCTOBER 20, 2022
The 340B Drug Pricing Program is 30 years old this year, but as The New York Times recently spelled out , the program has become a profit engine for large health systems over the years instead of a program that helps vulnerable, low-income patients. Powerful hospitals have twisted the program to boost their bottom line.
Drug Topics
OCTOBER 20, 2022
Adults who receive influenza and pneumococcal vaccines may be more likely to receive COVID-19 vaccines and boosters.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
OCTOBER 20, 2022
Study finds daily supplementation with cod liver oil for 6 months during the SARS-CoV-2 pandemic did not reduce the incidence of SARS-CoV-2 infection.
European Pharmaceutical Review
OCTOBER 20, 2022
In recent years there has been significant development within the cell therapy field, as chimeric antigen receptor (CAR) T-cell therapy demonstrated an ability to transform the treatment of patients with haematological malignancies. Recognising the potential of CAR T cells to act as highly targeted therapeutics, several biotechnology companies – including Sangamo Therapeutics – have established development pipelines of CAR T regulatory cells (Tregs) that aim to tackle immune?
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
OCTOBER 20, 2022
Rachel K. Anderson, PharmD, CSP, clinical program manager at Alliance Rx Walgreens Pharmacy, discusses the impact pharmacists have on the care journey for patients with multiple myeloma.
pharmaphorum
OCTOBER 20, 2022
And the LIVE coverage continues as we head into Day Two… This day is set to hold even more points of interest, with the demonstration ‘CX innovation: building experiences that work for customers’ (moderated by Healthware Group’s global head of digital strategy and customer engagement Yannick Valenti), as well as the masterclass ‘How to maximise learning science to affect behaviour change’ with Meducate Global’s president, Lawrence Sherman, and MD of Healthware MedComms & SWM, Francis M
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
OCTOBER 20, 2022
In 2018, the researcher Pranav Rajpurkar was working on an algorithm that could find blood clots in patients’ legs from ultrasound images. It spotted them very well, but when he went looking for what the algorithm had picked up on in the images to make its predictions, he saw it had been cheating: it was looking at the metadata in the top right corner of every ultrasound.
Pharmacy Times
OCTOBER 20, 2022
Staying informed through the right sources and being mindful of antibiotic usage can help health care providers and patients be more prepared for future pandemics.
Drug Topics
OCTOBER 20, 2022
What does the uptake look like for one of the most common vaccines given during pregnancy—and what does this mean for the future?
Pharmacy Times
OCTOBER 20, 2022
In a panel, pharmacy technicians across the world discuss the differences of the role for pharmacy technicians in United States, Portugal, and the United Kingdom.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
OCTOBER 20, 2022
Your job can be hazardous to your health, according to a new report from the U.S. Surgeon General that highlights how the Covid-19 pandemic has revealed fractures in working Americans’ mental health and well-being. Released Thursday, the report cites workplace trends like quiet quitting and the Great Resignation as signals of the damage done to Americans by problems like endless hours, unpaid leave, and chronic stress.
European Pharmaceutical Review
OCTOBER 20, 2022
Apogenix , a biopharmaceutical company developing next generation immunotherapeutics, announced that asunercept showed statistically significant benefits for hospitalised COVID-19 patients in the ASUNCTIS trial. Apogenix’s lead immunotherapy candidate, asunercept is a fully human fusion protein, consisting of the CD95 receptor and an IgG1 antibody. It is being developed for the treatment of solid tumours, haematological malignancies and viral infections such as COVID-19.
STAT
OCTOBER 20, 2022
When the news came out last month that an experimental Alzheimer’s therapy succeeded in a clinical trial , it provided a rare boost of hope for the millions facing the condition. A select group of patients felt something more: lucky. In interviews, people who participated in the trial and their caregivers described a gratitude at somehow winding up in a study where the drug actually worked, against a backdrop of repeated failures to develop effective Alzheimer’s medications.
Drug Topics
OCTOBER 20, 2022
Determining the characteristics that impact antibiotic prescribing behavior is important for addressing health inequity.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
OCTOBER 20, 2022
Amid a push to widen access to medicines to poor countries, Novartis has reached an agreement to license one of its best-selling cancer treatments so that generic manufacturers can produce copies for distribution to 44 low- and middle-income nations. The deal with the Medicines Patent Pool, a public health organization backed by the United Nations, marks the first time that a voluntary licensing deal has been arranged for a cancer medication.
PharmaVoice
OCTOBER 20, 2022
The healthcare giant showed pharmaceutical gains, but that's no thanks to the economic environment of persistent inflation and a strong U.S. dollar.
STAT
OCTOBER 20, 2022
The Inflation Reduction Act of 2022 mandates that Medicare-covered drug sales will be protected from price increases that exceed inflation, but the mechanics of this “inflation penalty” have generated some confusion. A top Medicare official recently noted that the per-pill value of the Medicare inflation penalty will be calculated based on average prices across both the Medicare and commercial markets, but the penalty will be paid only on prescriptions reimbursed by Medicare.
pharmaphorum
OCTOBER 20, 2022
Executing an effective commercial success strategy requires extensive planning and implementation within pharmaceutical companies that spans teams, functions, and geographies. Together, these groups compile vast amounts of data, including rich information on patient populations, target customers, and the competitive landscape. But after months of effort, in most cases, the usefulness of this data begins and ends in a static slide deck or spreadsheet.
STAT
OCTOBER 20, 2022
Three dozen institutional investors are urging the boards at several of the world’s largest pharmaceutical companies to establish concrete metrics for linking executive compensation with policies that widen access to medicines to low- and middle-income countries. In a series of letters, the investors asked the heads of board compensation committees to examine such steps as voluntary licensing agreements and technology transfer for generic production; supply chain performance for improving
European Pharmaceutical Review
OCTOBER 20, 2022
City of Hope , one of the largest cancer research and treatment organisations in the US, announced that the first patient to receive novel cancer medicine AOH1996, is doing well. The Phase I clinical trial is open at City of Hope Los Angeles. Its objective is to determine the maximum tolerated dose of the investigational pill, AOH1996, and to evaluate the medicine for preliminary efficacy.
STAT
OCTOBER 20, 2022
What happens when approved drugs turn out not to work? Is it OK to make SARS-CoV-2 hybrids? And are British tabloids reliable sources of science news? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Lawyer and bioethicist Holly Fernandez Lynch joins us to explain a watershed test of the FDA’s authority to revoke drug approvals.
European Pharmaceutical Review
OCTOBER 20, 2022
An essential part of the manufacturing of drug products is the use of water of different degrees of purity. The US Food and Drug Administration (FDA) defines eight different types of water: non-potable, potable (drinkable), purified, water for injection (WFI), sterile water for injection, sterile water for inhalation, bacteriostatic water for injection and sterile water for irrigation. 1 The last four are produced at separate plants and thus less discussed for pharma since they are unlikely to b
STAT
OCTOBER 20, 2022
After years of stops and starts, a law was finally passed in Congress this summer to address the rising cost of prescription medicines. The Inflation Reduction Act allows the federal government to negotiate prices for some costly drugs, but only a small number that cost the government the most money. But those medicines can’t have any competing products on the market, and negotiations can’t begin until a small-molecule drug has been available for at least nine years and a biologic
pharmaphorum
OCTOBER 20, 2022
In mid-October, our Web Editor Nicole Raleigh and Deep Dive Editor Eloise McLennan travelled to Nice for the Reuters Pharma event. This special episode includes a conversation recorded on-site with Nicole, Eloise, Virtual Science AI CEO Thomas Hughes, and VSAI VP of global patient affairs Geraldine Reilly. They discuss key takeaways from the event, major trends in the space, and the guests’ work at Virtual Science AI, using technology to help life sciences companies create virtual patient adviso
STAT
OCTOBER 20, 2022
Top of the morning to you. Another deliciously shiny day is unfolding over the Pharmalot campus, where the skies are blue and a cool breeze is circulating. Although there is much work to be done, please join us as we pause ever so briefly to relish the moment with a tasty cup of stimulation — our choice today is peppermint mocha. After all, life is short, so why not stop to appreciate, yes?
Pharmacy Times
OCTOBER 20, 2022
There is currently no approved RSV vaccine despite ongoing research efforts.
PharmaVoice
OCTOBER 20, 2022
Colossal Biosciences announced the creation of Form Bio — and its “operating system for science” — in September.
European Pharmaceutical Review
OCTOBER 20, 2022
Gedeon Richter has announced that its combined oral contraceptive Drovelis® is the first tablet containing estetrol (E4) and drospirenone (DRSP) to be made available on the NHS in England. The drug (14.2mg estetrol and 3mg drospirenone) is the first oral combined contraceptive containing a new, synthetic natural oestrogen to be offered to patients in the UK.
Drug Topics
OCTOBER 20, 2022
A selection of the latest COVID-19 vaccine research out of IDWeek 2022.
The Guardian - Pharmaceutical Industry
OCTOBER 20, 2022
Country investigating 206 cases of kidney injury that could be linked to ingredients in liquid medicines Indonesia has banned the sale of all syrup medicines as it investigates the deaths this year of nearly 100 children, warning that the liquids may contain ingredients linked to fatal kidney injuries. The move comes just weeks after the World Health Organization issued an alert over four Indian-made cough syrups that it said were potentially linked with acute kidney injuries and the deaths of 7
Drug Topics
OCTOBER 20, 2022
The new restrictions include both independent and chain pharmacies.
Pharmacy Times
OCTOBER 20, 2022
Improved workflow and optimal patient outcomes occur when technicians serve as vital members of the health care team, across the continuum of care.
Drug Store News
OCTOBER 20, 2022
Drug Store News Editor-in-Chief Nigel Maynard talks with Dan Mack about his latest book, "Look Closer: Ideas on Reexamining and Eliminating Personal, Relational, and Organizational Blind Spots.
Pharmacy Times
OCTOBER 20, 2022
Sonidegib binds to and inhibits a transmembrane protein to disrupt hedgehog pathway signal transduction and leading to antitumor activity in patients with locally advanced basal cell carcinoma.
Expert insights. Personalized for you.
240 
Let's personalize your content